These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37161965)

  • 41. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
    Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
    Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood.
    Li R; Wang J; Li X; Liang Y; Jiang Y; Zhang Y; Xu P; Deng L; Wang Z; Sun T; Wu J; Xie H; Wang Y
    Cancer Sci; 2024 Jan; 115(1):94-108. PubMed ID: 37962061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors.
    Jackson LP; Tjoa BA; Mellert H; Pestano GA
    Cancer Drug Resist; 2020; 3(3):563-571. PubMed ID: 35582444
    [No Abstract]   [Full Text] [Related]  

  • 44. Revealing Clonal Responses of Tumor-Reactive T-Cells Through T Cell Receptor Repertoire Analysis.
    Aoki H; Shichino S; Matsushima K; Ueha S
    Front Immunol; 2022; 13():807696. PubMed ID: 35154125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations.
    Cao Y; Wang J; Hou W; Ding Y; Zhu Y; Zheng J; Huang Q; Cao Z; Xie R; Wei Q; Qin H
    Gut Microbes; 2023 Dec; 15(2):2263934. PubMed ID: 37795995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA.
    Baker AM; Nageswaran G; Nenclares P; Ronel T; Smith K; Kimberley C; Laclé MM; Bhide S; Harrington KJ; Melcher A; Rodriguez-Justo M; Chain B; Graham TA
    Cancer Res; 2024 May; 84(10):1560-1569. PubMed ID: 38479434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
    Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
    J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transient Depletion of CD4
    Aoki H; Ueha S; Shichino S; Ogiwara H; Shitara K; Shimomura M; Suzuki T; Nakatsura T; Yamashita M; Kitano S; Kuroda S; Wakabayashi M; Kurachi M; Ito S; Doi T; Matsushima K
    Cancer Immunol Res; 2021 Jun; 9(6):624-636. PubMed ID: 33674357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma.
    Spassova I; Ugurel S; Terheyden P; Sucker A; Hassel JC; Ritter C; Kubat L; Habermann D; Farahpour F; Saeedghalati M; Peiffer L; Kumar R; Schrama D; Hoffmann D; Schadendorf D; Becker JC
    Clin Cancer Res; 2020 May; 26(9):2257-2267. PubMed ID: 31932494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
    Yang XR; Pi C; Zhang YC; Chen ZH; Zhang XC; Zhu DQ; Yang LL; Yin JC; Deng JY; Yang MY; Luo WC; Wu YL; Zhou Q
    Mol Carcinog; 2023 Jul; 62(7):1001-1008. PubMed ID: 37067398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
    Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
    Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.
    Gkazi AS; Margetts BK; Attenborough T; Mhaldien L; Standing JF; Oakes T; Heather JM; Booth J; Pasquet M; Chiesa R; Veys P; Klein N; Chain B; Callard R; Adams SP
    Front Immunol; 2018; 9():2547. PubMed ID: 30455696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.
    Donadon M; Hudspeth K; Cimino M; Di Tommaso L; Preti M; Tentorio P; Roncalli M; Mavilio D; Torzilli G
    J Gastrointest Surg; 2017 Aug; 21(8):1226-1236. PubMed ID: 28536806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
    Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
    BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.
    Lim B; Mun J; Kim JH; Kim CW; Roh SA; Cho DH; Kim YS; Kim SY; Kim JC
    Oncotarget; 2015 Sep; 6(26):22179-90. PubMed ID: 26109429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pipeline to characterize antigen-specific TCR repertoires in tumors: Examples from an HPV16 tumor model.
    Rudqvist NP
    Methods Cell Biol; 2023; 180():15-24. PubMed ID: 37890928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
    Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
    J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
    Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
    Kobayashi K; Ono Y; Kitano Y; Oba A; Sato T; Ito H; Mise Y; Shinozaki E; Inoue Y; Yamaguchi K; Saiura A; Takahashi Y
    Ann Surg Oncol; 2023 Nov; 30(12):7338-7347. PubMed ID: 37365416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.
    Stremitzer S; Sunakawa Y; Zhang W; Yang D; Ning Y; Stintzing S; Sebio A; Yamauchi S; Matsusaka S; El-Khoueiry R; Stift J; Wrba F; Gruenberger T; Lenz HJ
    Pharmacogenomics J; 2015 Dec; 15(6):521-9. PubMed ID: 25752522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.